Method to identify a patient with an increased likelihood of responding to an anti-cancer… Application EP-2866032-A1 European Patent Office 29 Apr 2015
Method to identify a patient with an increased likelihood of responding to an anti-cancer… Application EP-2848939-A1 European Patent Office 18 Mar 2015
Method to identify a patient with an increased likelihood of responding to an anti-cancer… Application EP-2848940-A1 European Patent Office 18 Mar 2015
Plasma biomarker for bevacizumab combination therapy for breast cancer treatment Application JP-2015502543-A Japan 22 Jan 2015
Method to identify a patient with an increased likelihood of responding to an anti-cancer… Application EP-2801826-A1 European Patent Office 12 Nov 2014
Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast… Application CN-104067128-A China 24 Sep 2014
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST… Application WO-2013083499-A1 World Intellectual Property Organisation (WIPO) 13 Jun 2013
METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER… Application WO-2012010547-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2012
METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER… Application WO-2012010550-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2012
METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER… Application WO-2012010549-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2012
METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER… Application WO-2012010548-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2012